✦ LIBER ✦

Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag

✍ Scribed by Kathlyn Santos; Cindy M.P. Duke; Sol M. Rodriguez-Colon; Anthony Dakwar; Shongshan Fan; Michael C. Keefer; Howard J. Federoff; John G. Frelinger; William J. Bowers; Stephen Dewhurst

Book ID: 116959412
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 531 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.11.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a modified

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

✍ Felipe García; Juan Carlos López Bernaldo de Quirós; Carmen E. Gómez; Beatriz Pe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Effects of mutations in an HIV-1 gag gen

Effects of mutations in an HIV-1 gag gene containing a 107-codon tandem repeat in the matrix region on assembly and processing of the protein product

✍ Wei-Hao Liao; Hsu-Chen Chiu; Chin-Tien Wang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 1 views

## Abstract It has been demonstrated previously that a human immunodeficiency virus (HIV) type 1 Gag mutant (MA2) with a tandem repeat of 107‐matrix codons in the matrix domain could direct virus particle assembly and budding [Wang et al. (2000c): J Med Virol 61:423–432]. Since the regions involved